Cargando…
Risk factors for venous irritation in patients receiving vinorelbine: a retrospective study
BACKGROUND: Vinorelbine is known to be effective in the treatment of non-small cell lung cancer and breast cancer. However, venous irritation is a common side effect. Although there have been some reports on risk factors for venous irritation in patients receiving vinorelbine, the factors evaluated...
Autores principales: | Morimoto, Yoshihito, Miyawaki, Kumika, Seki, Reisuke, Watanabe, Kazuhiro, Hirohara, Masayoshi, Shinohara, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166274/ https://www.ncbi.nlm.nih.gov/pubmed/30288295 http://dx.doi.org/10.1186/s40780-018-0122-2 |
Ejemplares similares
-
Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432
por: Morimoto, Yoshihito, et al.
Publicado: (2018) -
Vinorelbine – a clinical review
por: Gregory, R K, et al.
Publicado: (2000) -
Joint symptoms associated with anastrozole and letrozole in patients with breast cancer: a retrospective comparative study
por: Morimoto, Yoshihito, et al.
Publicado: (2017) -
Oral vinorelbine in metastatic breast cancer
por: Conte, PF, et al.
Publicado: (2005) -
Vinorelbine Augments Radiotherapy in Hepatocellular Carcinoma
por: Yeoh, Kheng Wei, et al.
Publicado: (2020)